QP-Breast®
Leverages MRI sequences to personalize treatment strategies
To streamline MRI interpretation in breast cancer patients through an AI-assisted workflow, Quibim is working on a new product that will be of help for lesion characterization, allowing to identify disease subtypes and linking imaging features with patient outcomes. Being able to provide oncologists with a clear answer will allow them to further personalize treatment plans through the combination of imaging with molecular biology information.